.

OracleBio adds HALO AI Quantitative Digital Pathology capabilities to support Clinical R&D Data Generation to a Regulatory Standard
⚡ Article Synopsis: In this latest article, our GCP team talks about the exciting next phase of our Good Clinical Practice services, which have now launched. Expect to learn more about the client benefits. the process of analysing histology images to a regulatory standard, and more.

For almost 3 years, OracleBio has been offering quantitative image analysis services within a Good Clinical Practice (GCP) compliant environment, enabling the generation of quantitative digital pathology data to a regulatory standard.

As part of our commitment to continuous improvement, we have recently added AI-powered image analysis capabilities within a scalable cloud-based (Amazon Web Services; AWS) IT environment, with the establishment of Indica Labs’ HALO AI software.

This innovative addition has been developed, constructed, and fully validated within our existing quality management framework (QMF), providing a highly controlled and auditable environment for detailed and efficient image analysis.

Client Benefits

The integration of AI-powered algorithms can improve accuracy around challenging tissue and/or cell segmentation requirements within chromogenic, immunofluorescence single or multiplex staining across morphologically heterogeneous tissue sample images.

The ability to analyse images in the AWS cloud environment provides access to scalable Central Processing Units (CPUs) and Graphics Processing Units (GPUs) on demand – this can significantly improve analysis turn-around time while helping to manage image processing costs.

Ultimately, these combined additions help to deliver more accurate data and to improve the efficiency of data generation.

Furthermore, we provide the ability for a Client’s own HALO AI algorithms to be transferred and integrated into our GCP workflow, creating improved value from your internal translational R&D image analysis activities.

The Process

Our comprehensive ‘Quality Managed Workflow’ for regulatory studies principally involves 2 parts, which allow Histology images to be analysed to a regulatory standard:

  • Part 1: The development and validation of algorithms specific for the study images to be analysed. The algorithms can be developed by OracleBio or transferred from the Client. This requires regular communication with the Client, covering the initial proposal based on the analysis approach and required read-outs, through to approval of the study plan and establishing a validated algorithm through a series of defined and auditable steps.
  • Part 2: This involves the application of the validated algorithms across the tissue image study set, following an agreed and transparent workflow. Every step of this process involves communication with the Client through continuous review and milestone decisions in the study.

The efficiency of our workflow revolves around critical elements present throughout the study. The key to this is not only clear communication but continuous attention to quality control and oversight from our quality assurance – in fact, our Clients see us as an extension of their project team.

Our mission of continuous improvement means that this important update was a natural next phase of our GCP services, one that utilises the power and precision of HALO AI.

We see this as a real value-add for the R&D community, which will further support important clinical studies. We’re excited to see the growing interest in this area and the commitment to GCP studies our clients have.

In the second part of this 2-part GCP update, we’ll take a more detailed look at our quality management system, framework, workflow, and more. Keep an eye out for it in the coming weeks!

In the meantime, if you’d like to find out more about our GCP services and how we can help take your clinical R&D to the next level, we’d love to hear from you.

You can arrange a chat with our team here.

How OracleBio can support you

Why work with OracleBio?

Stay up to date with OracleBio

Sign up to our mailing list to stay informed about news, webinars, events and more